News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Novel KRAS G12C inhibitor shows promising antitumour activity in mutated pancreatic cancer
11 Feb 2023
The investigational KRAS G12C inhibitor sotorasib appears to be active against previously treated KRAS p.G12C–mutated advanced pancreatic cancer while having an acceptable safety profile, according to the results of a phase I/II trial.
11 Feb 2023

Is first-line lazertinib monotherapy a potential new SoC for EGFRm NSCLC?
10 Feb 2023
byRoshini Claire Anthony
Patients with EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) exhibited significantly improved progression-free survival (PFS) when treated with lazertinib compared with gefitinib in the first-line setting, results of the LASER301 trial showed.
10 Feb 2023

Herbal combo regimen shows promise for ulcerative colitis
10 Feb 2023
byAudrey Abella
A combination regimen comprising two herbal extracts – curcumin and Qing Dai (QD) – have shown potential in the treatment of active* ulcerative colitis (UC), according to two trials from Israel presented at Crohn’s & Colitis Congress (CCC) 2023.
10 Feb 2023






